Tvardi Therapeutics, Inc. (TVRD)
(Delayed Data from NSDQ)
$23.93 USD
+0.81 (3.48%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $23.46 -0.47 (-1.94%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Tvardi Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
TVRD 23.93 +0.81(3.48%)
Will TVRD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TVRD based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for TVRD
Tvardi Therapeutics management to meet with Piper Sandler
Tvardi Therapeutics management to meet with Piper Sandler
Upcoming Meetings for TVRD Scheduled in Boston and New York | TVRD Stock News
Tvardi Therapeutics management to meet with Piper Sandler
Tvardi Therapeutics to Participate in the BTIG Virtual Biotechnology Conference | TVRD Stock News